Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.

MLA

de Seze, J., et al. “Effect of Glatiramer Acetate (Copaxone) given Orally in Human Patients: Interleukin-10 Production during a Phase 1 Trial.” Annals of Neurology, vol. 47, no. 5, May 2000, p. 686. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10805349&authtype=sso&custid=ns315887.

APA

de Seze, J., Edan, G., Labalette, M., Dessaint, J. P., & Vermersch, P. (2000). Effect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial. Annals of Neurology, 47(5), 686.

Chicago

de Seze, J, G Edan, M Labalette, J P Dessaint, and P Vermersch. 2000. “Effect of Glatiramer Acetate (Copaxone) given Orally in Human Patients: Interleukin-10 Production during a Phase 1 Trial.” Annals of Neurology 47 (5): 686. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10805349&authtype=sso&custid=ns315887.